The downregulation or loss of cell surface expression of HLA-I and high resistance to NK-cell-mediated killing has been described in ALL (97–101)—for instance, the C2 epitope that is encoded by HLA-C has been found to be overrepresented in patients with ALL. The gene discussed is HLA-C; the disease is acute lymphoblastic leukemia.